Hemophilia Patient Recruitment in Rhode Island

TheraNovex connects clinical trial sponsors with pre-screened, eligible Hemophilia patients across Rhode Island, including Providence, Cranston, Warwick, and beyond.

Hemophilia A and B patient recruitment for factor replacement, gene therapy, and non-factor therapy clinical trials.

Who qualifies: Males with severe or moderate hemophilia A or B (factor activity <5%), with or without inhibitors.

Recruitment challenges: Factor activity level requirements and inhibitor status eligibility criteria.

Our approach: Hemophilia treatment center networks, NHF chapter partnerships, and factor activity pre-screening.

Our recruitment network spans all major metropolitan areas in Rhode Island, ensuring broad geographic coverage for your Hemophilia trial.